“…In addition, it will help generate critical evidence for the interpretation of globin gene variants based on the ACMG/AMP framework, an approach also followed by other VCEPs. 19 Furthermore, the integration of EMQN guidelines into IthaPhen facilitates, but does not replace, genetic diagnosis and genetic counseling for hemoglobinopathies, particularly in countries with limited experience and less exposure to hemoglobinopathies. Notably, we demonstrated the utility of IthaPhen with 2 examples in (a) genotype-phenotype correlation and (b) standardized variant classification, illustrating how IthaPhen can contribute to data-driven and quantitative approaches in the field of hemoglobinopathies.…”